Nancy Lurker

Insider Reports History

Entity
Individual
Location
Pdi, Inc., 1 Route 17 South, Saddle River, NJ
Signature
/s/ Shantale Greenson, attorney-in-fact for Nancy Lurker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Lurker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 205K $1.33M $6.50 Feb 9, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Common Stock 127K $824K $6.50 Feb 9, 2025 By Family Trust
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 May 31, 2024 Direct
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 12.7K $428K $33.64 Feb 4, 2025 Direct
Alkermes plc. Director Ordinary Shares 4.62K $125K $27.00 Apr 11, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Restricted Stock Units 0 $0 $6.50 Feb 9, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K Jan 3, 2025 Direct
Aquestive Therapeutics, Inc. Director Stock Option (Right to Purchase) 20K Jun 15, 2021 Direct
Alkermes plc. Director Restricted Stock Unit Award 7.5K Apr 11, 2025 Direct

Insider Reports Filed by Nancy Lurker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALKS Alkermes plc. Apr 11, 2025 6 -$39.4K 4 Apr 14, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2025 2 $0 4 Feb 11, 2025 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Feb 4, 2025 1 $0 4 Feb 5, 2025 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Feb 4, 2025 0 $0 3 Feb 5, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 3, 2025 5 $0 4 Jan 7, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Aug 16, 2024 1 $25K 4 Aug 20, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jul 26, 2024 10 $0 4 Jul 26, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jul 10, 2024 2 $0 4 Jul 12, 2024 Executive Vice Chair, Director
ALKS Alkermes plc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
ALKS Alkermes plc. Apr 11, 2024 4 $0 4 Apr 12, 2024 Director
ALKS Alkermes plc. Mar 5, 2024 0 $0 3 Mar 15, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2024 14 -$430K 4 Feb 13, 2024 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 23, 2024 4 -$874K 4 Jan 25, 2024 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 5 -$470K 4 Jan 9, 2024 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Dec 28, 2023 8 $0 4/A Jan 3, 2024 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Dec 28, 2023 6 $0 4 Jan 2, 2024 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Dec 4, 2023 1 -$415K 4 Dec 6, 2023 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Jul 10, 2023 2 $0 4 Jul 12, 2023 Executive Vice Chair, Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 1 $0 4 Jun 22, 2023 CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. May 11, 2023 14 $0 4 May 15, 2023 CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2023 4 $0 4 Feb 13, 2023 CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 6, 2023 1 $0 4 Jan 10, 2023 CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 28, 2022 2 $0 4 Mar 2, 2022 President & CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 21, 2022 2 $0 4 Feb 23, 2022 President & CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2022 4 $0 4 Feb 11, 2022 President & CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Nov 15, 2021 1 -$201K 4 Nov 17, 2021 President & CEO, Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 22, 2021 2 $0 4 Jun 23, 2021 President & CEO, Director
AQST Aquestive Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 14, 2021 2 $0 4 Jun 15, 2021 President & CEO, Director